The following transactions were advised on by K3 Capital Advisory and its senior team, operating as a trading name of Quantuma. They span debt raises, equity processes, management buy-outs and business sales across a range of sectors and deal sizes.
Showing 6 of 6 deals
K3 Capital Advisory advised 4D Capital on the carve-out acquisition of Hepworth Clay from a listed global group, providing bid strategy, transaction structuring and a competitive debt raise to fund the purchase. The mandate combined buyside advisory and debt advisory disciplines to deliver a complete acquisition solution.
2023-10
K3 Capital Advisory structured and negotiated a bespoke working capital facility from Optimum Finance for Bright A Blind, a London-based specialist in commercial blind cleaning and maintenance. The facility was sized to the operating cycle of the business, giving management the headroom to take on larger contracts and manage seasonal cash flow.
2023-06
K3 Capital Advisory structured a refinancing for Douglas Baker Plastics that enabled shareholders to realise partial value, retain a 25% equity stake and introduce an experienced chairman to support the next phase of growth. The transaction reshaped the balance sheet while providing fresh capital for the business to deploy.
2023-11
K3 Capital Advisory advised on the management buyout of Harris Evolution, structuring a NatWest-backed transaction that brought the senior management team into ownership and provided a clean exit for the departing shareholder. The deal was structured to support continuity of operations and give the incoming management team a platform for future growth.
2023-08
K3 Capital Advisory advised the shareholders of Lifecast Body Simulation on its sale to 3B Scientific, a Germany-based global leader in anatomical models and medical training equipment. The process was run as a competitive strategic marketing exercise, resulting in a cross-border transaction that recognised the premium value of Lifecast's proprietary simulation products.
2023-07
K3 Capital Advisory advised MyWorkpapers on a £3.4m Series A raise from Percipient Capital, structuring the investment to support platform development, sales team expansion and wider market growth. The round was positioned around demonstrable product traction and a clear path to increased recurring revenue.
2023-09
Advising on your next transaction.
Tell us what you are working on. Most mandates can be assessed in a short first call.
